Article Information
History
- January 8, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Emily Toscano-Guerra1,2,3,*,
- Valentina Maggio1,
- Javier García1,
- Maria Eugenia Semidey4,
- Ana Celma5,
- Juan Morote5,
- Inés de Torres4,
- Marina Giralt2,
- Roser Ferrer2 and
- Rosanna Paciucci1,2,*
- 1Cell Signaling and Cancer Progression Laboratory, Vall d’Hebron Institute of Research (VHIR), Barcelona, Spain
- 2Biochemistry Service, Vall d’Hebron Hospital, Barcelona, Spain
- 3Universidad Peruana Cayetano Heredia, Lima, Perú
- 4Department of Pathology, Vall d’Hebron Hospital, Barcelona, Spain
- 5Department of Urology, Vall d’Hebron Hospital, Barcelona, Spain
- ↵*Correspondence: Dr. Rosanna Paciucci, Biochemistry Service, Vall d’Hebron Hospital, Barcelona, Spain. rospacbar{at}gmail.com; Dr. Emily Toscano-Guerra, Cell Signaling and Cancer Progression Laboratory, Vall d’Hebron Institute of Research (VHIR), Barcelona, Spain. ema.tg27{at}gmail.com
Posted January 08, 2024.
Association of the rs1042522 SNP with prostate cancer risk: a study of cancer tissues, primary tumor cultures and serum samples from a European Caucasian population
